Hansa Biopharma and Genethon collaborate to test imlifidase as gene therapy pre-treatment 09-May-2023 By Isabel Cameron Hansa Biopharma and Genethon have entered a research and development collaboration to test imlifidase as a gene therapy treatment in patients with pre-existing neutralizing antibodies.
Sarepta licenses therapy to boost gene therapies 06-Jul-2020 By Ben Hargreaves Sarepta signs agreement with Hansa to use its treatment as part of a gene therapy treatment schedule.
